Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
The Journal of Clinical Psychiatry
|
August 1, 1986
Therapeutic effects of pindolol on behavioral disturbances associated with organic brain disease: a double-blind study
R M Greendyke, D R Kanter
Journal of Clinical Psychopharmacology
|
June 1, 1987
Plasma propranolol levels and their effect on plasma thioridazine and haloperidol concentrations
R M Greendyke, D R Kanter
Life Sciences
|
November 1, 1982
Schizophrenia and reduced cyclic AMP production: evidence for the role of receptor-linked events
D L Garver, C Johnson, D R Kanter
Journal of Clinical Psychopharmacology
|
June 1, 1984
Clinical relevance of thiothixene plasma levels
M L Mavroidis, D R Kanter, J Hirschowitz, et al.
Psychopharmacology
|
January 1, 1983
Clinical response and plasma haloperidol levels in schizophrenia
M L Mavroidis, D R Kanter, J Hirschowitz, et al.
The Journal of Clinical Psychiatry
|
September 1, 1984
Fluphenazine plasma levels and clinical response
M L Mavroidis, D R Kanter, J Hirschowitz, et al.
Psychopharmacology
|
January 1, 1984
Adrenergic-receptor desensitization and course of clinical improvement with desipramine treatment
M L Mavroidis, D R Kanter, D N Greenblum, et al.
American Journal of Clinical Pathology
|
September 1, 1985
A comparison of differential white blood cell counts using manual technic and the Coulter S-Plus IV
R M Greendyke, D R Kanter, L DeBoover, et al.
The Journal of Nervous and Mental Disease
|
May 1, 1986
Propranolol treatment of assaultive patients with organic brain disease. A double-blind crossover, placebo-controlled study
R M Greendyke, D R Kanter, D B Schuster, et al.
The American Journal of Psychiatry
|
August 1, 1981
Physostigmine and lithium response in the schizophrenias
P Edelstein, J R Schultz, J Hirschowitz, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
The Journal of Clinical Psychiatry
|
August 1, 1986
Therapeutic effects of pindolol on behavioral disturbances associated with organic brain disease: a double-blind study
R M Greendyke, D R Kanter
Journal of Clinical Psychopharmacology
|
June 1, 1987
Plasma propranolol levels and their effect on plasma thioridazine and haloperidol concentrations
R M Greendyke, D R Kanter
Life Sciences
|
November 1, 1982
Schizophrenia and reduced cyclic AMP production: evidence for the role of receptor-linked events
D L Garver, C Johnson, D R Kanter
Journal of Clinical Psychopharmacology
|
June 1, 1984
Clinical relevance of thiothixene plasma levels
M L Mavroidis, D R Kanter, J Hirschowitz, et al.
Psychopharmacology
|
January 1, 1983
Clinical response and plasma haloperidol levels in schizophrenia
M L Mavroidis, D R Kanter, J Hirschowitz, et al.
The Journal of Clinical Psychiatry
|
September 1, 1984
Fluphenazine plasma levels and clinical response
M L Mavroidis, D R Kanter, J Hirschowitz, et al.
Psychopharmacology
|
January 1, 1984
Adrenergic-receptor desensitization and course of clinical improvement with desipramine treatment
M L Mavroidis, D R Kanter, D N Greenblum, et al.
American Journal of Clinical Pathology
|
September 1, 1985
A comparison of differential white blood cell counts using manual technic and the Coulter S-Plus IV
R M Greendyke, D R Kanter, L DeBoover, et al.
The Journal of Nervous and Mental Disease
|
May 1, 1986
Propranolol treatment of assaultive patients with organic brain disease. A double-blind crossover, placebo-controlled study
R M Greendyke, D R Kanter, D B Schuster, et al.
The American Journal of Psychiatry
|
August 1, 1981
Physostigmine and lithium response in the schizophrenias
P Edelstein, J R Schultz, J Hirschowitz, et al.
Page
of 2